Rahman MS, Karim MR, Haque MA. Efficacy of Rifaximin in Diarrhoea Predominant Irritable Bowel Syndrome: A Placebo Controlled Clinical Trial. Med. Today [Internet]. 2023 Apr. 13 [cited 2024 Jun. 30];35(1):44-8. Available from: https://banglajol.info/index.php/MEDTODAY/article/view/64940